Table: Genmont Biotech Apr Rev NT$37.8M Vs NT$39.9M

About this update from Genmont Biotech, Inc.

Genmont Biotech Inc. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$37,785,000 NT$39,947,000 Jan-Apr Revenue NT$126,955,000 NT$139,399,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].

View stock analysis, news, and events for Genmont Biotech, Inc.